The size of the complementary and alternative medicine market is an ‘indictment against the conventional medical industry,’ says F. Perry Wilson. What can be done to reverse this growing trend? Medscape
Tag: Commentary
A Breakthrough Year in Retina Research
Dr Charles Wykoff highlights the many innovations in retina research in 2019, from the milestone moment of gene therapy to the diagnostic promise of artificial intelligence. Medscape Ophthalmology
Public Commenting Has Been Hijacked by Biopharma
In a recent analysis, 1 in 2 ‘public commenters’ giving input on state-level drug coverage decisions was someone with financial ties to the pharmaceutical industry. Medscape Oncology
These NASA Docs Keep an Eye on Astronaut Health
Dr Andrew Wilner speaks with NASA researchers about the latest data on a neuro-ocular syndrome that can occur after spaceflight. Medscape Neurology
FLUID Study Rethinks Treat-and-Extend in Neovascular AMD
Study results show that some subretinal fluid can be tolerated after anti-VEGF injections without sacrificing visual outcomes. Dr Charles Wykoff explains why it may not be that simple. Medscape Ophthalmology
Making Referrals Work for Physicians and Patients
Sending your patients to specialists is more complex than it once was, but some simple tips can make the process more beneficial for all. Medscape Optometry
Ultra-Processed Foods: Ultra-Toxic or Just Ultra-Tasty?
A recent study in Cell Metabolism linked consumption of ultra-processed foods with overeating and weight gain. So what’s different about these foods? Medscape
Two Updates in Multiple Sclerosis
Dr Stephen Krieger on when anti-MOG antibody testing is warranted, and how to properly manage the risk for post-fingolimod rebound. Medscape Neurology
Glaucoma: Overview Video
This video discusses the main types of glaucoma: open-angle glaucoma, closed-angle glaucoma, and normal-tension glaucoma. It also discusses key aspects of pathophysiology, diagnosis, and treatment. Osmosis
Age-Related Macular Degeneration: 5 Things to Know
A guide to the latest on this chronic disease, from emerging treatments to the risk factors to be on the lookout for. Medscape Ophthalmology
Skipping Treatment for Diabetic Retinopathy Carries Risks
Drs Jason Hsu and Anthony Obeid on how the 25% of patients lost to follow-up are vulnerable to vision loss and other adverse outcomes. Wills Eye Hospital
What Do You Think About Retirement?
Is it healthier to retire or keep working? The answer may surprise you. Medscape Internal Medicine
A ‘Critical Eye’ on Patient Confidentiality in Eye Care
A clinician stumbles on clinic employees curiously discussing a patient’s presentation with unauthorized information obtained from the chart. Does your office need a HIPAA review, too? Medscape Optometry
Nasolacrimal Duct Obstruction: The Right Way to Teach Parents
Constant tearing is a common complaint noted by parents of infants. And it’s not always the result of a nasolacrimal duct obstruction. CHOP Expert Commentary
A Secret to 5-Star Ratings: Prescribe Antibiotics
A new study confirms what many clinicians suspected: Patients reward and punish them for how they treat respiratory infections, reports Dr Perry Wilson. Medscape
When Dismissing a Patient, Avoid a ‘Bad Breakup’
Breaking up is always hard to do–particularly when it’s with a difficult patient. Take these steps to ensure a smooth transition. Medscape Optometry
Anti-VEGF vs PRP for Proliferative Diabetic Retinopathy
Five-year data from DRCR.net Protocol S provides needed comparative data on the efficacy, safety, and burden of these treatments. Medscape Ophthalmology
Diabetic Retinopathy: Reality and Risk of Loss to Follow-up
Clinical studies on the treatments for diabetic retinopathy have focused on efficacy and safety, but the loss of patients to follow-up is a challenge that may be affected by the choice of treatment. Medscape Ophthalmology
For Dry Eye, Transnasal Neurostimulator Activates Real Tears
Drs Rapuano and Meghpara describe a unique new device that helps patients with dry eye produce their own tears. Wills Eye Hospital
First Artificial Iris Approved
Following the recent approval by the US Food and Drug Administration (FDA) of the first artificial iris, Dr Brandon Ayres describes this groundbreaking solution for patients. Wills Eye Hospital